Related Experiment Video
Updated: Jun 5, 2026

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
Published on: June 13, 2021
[Treatment of bipolar disorder during pregnancy and in the postpartum period]
Jan Øystein Berle1, Dag Kristen Solberg, Olav Spigset
1Forskningsenheten, Psykiatrisk divisjon, Helse Bergen HF, Postboks 23 Sandviken, 5812 Bergen, Norway. jaob@helse-bergen.no
Background:
Pharmacological treatment and prophylaxis of bipolar disorders during pregnancy and in the postpartum period imply complicated clinical assessments.
Material And Method:
This article is based on a non-systematic search in PubMed and the authors' clinical experience.
Results:
If a woman is already using a prophylactic drug at the time of pregnancy, she can in general continue to do so during pregnancy, with the exception of valproate. If the disorder starts during pregnancy; lithium, lamotrigine or second generation antipsychotic drugs are suitable alternatives. In general, drugs used during pregnancy can also be used in the postpartum period, although some require special precautions if the mother wishes to breast-feed. If treatment is initiated after delivery, the mother's wish to breast-feed should be taken into consideration when choosing a drug.
Interpretation:
Although existing studies have weaknesses, there is sufficient evidence to give qualified advice regarding choice of medication for bipolar disorder during pregnancy and in the postpartum period.
Related Concept Videos
Mania and Antimanic Drugs: Overview
Bipolar Disorder
Psychosis: Goals of Pharmacotherapy
Drug Therapy
Antianxiety Medications
Psychosis and Antipsychotic Drugs: Overview
Electroconvulsive Therapy